Financhill
Back

ATAI Life Sciences NV Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
38

ATAI
ATAI Life Sciences NV

Last Price:
1.09
Seasonality Move:
-7.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

ATAI Life Sciences NV Price Quote

$1.09
+0.01 (+0.93%)
(Updated: November 5, 2024 at 5:14 AM ET)

ATAI Life Sciences NV Key Stats

Sell
38
ATAI Life Sciences NV (ATAI) is a Sell

Day range:
$1.08 - $1.13
52-week range:
$1.03 - $2.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.08%

Volume:
596.5K
Avg. volume:
661.7K
1-year change:
-17.8%
Market cap:
$182.1M
Revenue:
$314K
EPS:
$-0.39

How Much Does ATAI Life Sciences NV Make?

Data Unavailable

Is ATAI Life Sciences NV Growing As A Company?

  • What Is ATAI Life Sciences NV's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.59%
  • What Is ATAI Life Sciences NV's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

ATAI Life Sciences NV Stock Price Performance

What Is ATAI Life Sciences NV 52-Week High & Low?

ATAI Life Sciences NV Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ATAI Life Sciences NV?

Is ATAI Life Sciences NV Cash Flow Positive?

  • What Is ATAI Cash Flow From Operations?
    Cash flow from operations (TTM) is -$79.2M
  • What Is ATAI Life Sciences NV’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$8.1M
  • What Is ATAI Life Sciences NV’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$19.5M

ATAI Life Sciences NV Return On Invested Capital

  • Is Management Doing A Good Job?
    ATAI return on invested capital is -24.06%
  • What Is ATAI Life Sciences NV Return On Assets?
    ROA measures how assets are converting to revenues and is -21.67%
  • What Is ATAI Return On Equity?
    ROE is a measure of profitability and is -25.92%

ATAI Life Sciences NV Earnings Date & Stock Price

ATAI Life Sciences NV Competitors

ATAI Life Sciences NV Dividend Yield

ATAI Life Sciences NV Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -129.78%
Revenue: 58.72% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 9.25
Upside from Last Price: 752.53%

Major Shareholders

  • How many ATAI shares are owned by institutional investors?
    50.3M ATAI shares are owned by institutional investors
  • How many ATAI shares are owned by insiders?
    603.2K ATAI shares are owned by insiders